Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ERNA Eterna Therapeutics
4.760+0.110+2.37%
Close
02/03 16:00 ET
4.7600.0000.00%
Post Mkt Price 02/03 17:54 ET
High
4.866
Open
4.550
Turnover
80.54K
Low
4.550
Pre Close
4.650
Volume
16.84K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Eterna Therapeutics Chief Medical Officer to Resign
Eterna Therapeutics (NASDAQ:ERNA) Shares Down 1.7%
Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Rating)'s stock price dropped 1.7% on Wednesday . The company traded as low as $4.96 and last traded at $4.97. Approximately 11,002 shares traded hands dur
Eterna Appoints Angel as CEO, President
Eterna Therapeutics Names Matt Angel President, CEO >ERNA
Press Release: Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President
Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ("Eterna" or the "C
Eterna Therapeutics (NASDAQ:ERNA) Shares Down 7.3%
Shares of Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Rating) traded down 7.3% during trading on Tuesday . The company traded as low as $3.03 and last traded at $3.18. 13,899 shares traded hands duri
In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Dr. Matt Angel, CEO Eterna Therapeutics
NEW YORK, NY / ACCESSWIRE / December 20, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently iss
Insider Buying: Eterna Therapeutics Inc. (NASDAQ:ERNA) Major Shareholder Buys $1,101,817.60 in Stock
Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Rating) major shareholder John D. Halpern acquired 335,920 shares of the stock in a transaction on Friday, December 2nd. The stock was acquired at an avera
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAcelRx Pharmaceuticals (NASDAQ:ACRX) stock increased by 8.0% to $2.03 during Wednesday's after-market session. The market value of their outstanding shares is at $15.1 million. MEI Pharma (NASD
What's Going On With Eterna Therapeutics Stock Today?
Eterna Therapeutics Inc (NASDAQ:ERNA) shares initially surged Wednesday morning on recent insider buying, but the stock pulled back shortly after the market open. Eterna shares have shown elevated lev
Company Overview
More
Eterna Therapeutics Inc.(formerly Brooklyn ImmunoTherapeutics, Inc. ) is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.
CEO： Dr. Matthew Angel
Market： NASDAQ
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet